Responses
Regular and young investigator award abstracts
Clinical trials in progress
416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
